Back to search
FDAFDA · Food and drugs·Recall number D-1327-2019

Ipamorelin Acetate 9 mg/9mL Injectable vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846

Published June 19, 2019 · Recall initiated: May 23, 2019

Summary

FDA records drug Class II recall D-1327-2019, published June 19, 2019 and initiated May 23, 2019. Recalling firm: Pharm D Solutions, LLC; Status: Terminated; Reported quantity: 11 vials; Lot: Lot #: 05022019:50 Exp. 10/29/2019; 05082019:91 Exp. 06/08/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Sterility Assurance.

What to do

FDA Mandated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharm D Solutions, LLC
Distributor
Nationwide within the United States
Lot
Lot #: 05022019:50 Exp. 10/29/2019; 05082019:91 Exp. 06/08/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ipamorelin Acetate 9 mg/9mL Injectable vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846 recalled?

Yes. FDA published recall D-1327-2019 on June 19, 2019. Reported hazard: Lack of Sterility Assurance.

What should I do if I have this product?

FDA Mandated · Press Release